Volume 74, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The pharmacokinetics of primaquine have been well defined in male volunteers, but there is little data on the disposition of the drug in women. We compared the kinetics of primaquine in nine male and nine female healthy Australian volunteers after the administration of a single oral dose (30 mg base) of primaquine. No statistical differences were observed in the following kinetic parameters of primaquine between men and women, respectively: maximum plasma concentration (93 ± 26 and 115 ± 38 ng/mL; 95% confidence interval [CI] of the mean difference: −55 to 10 ng/mL; = 0.16), area under the curve (1.1 ± 0.5 and 1.2 ± 0.4 μg.h/mL; 95% CI: −0.6 to 0.3 μg.h/mL; = 0.54), and clearance (0.34 ± 0.12 and 0.39 ± 0.14 L/h/kg; 95% CI: −0.17 to 0.08 L/h/kg; = 0.46). The clinical relevance of such findings would suggest that sex does not have to be taken into account as a factor when prescribing primaquine for radical cure or terminal prophylaxis of malaria.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2000. Practical Chemotherapy of Malaria. Geneva, Switzerland: World Health Organization.
  2. Baird JK, Rieckmann KH, 2003. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 19 : 115–120.
    [Google Scholar]
  3. Nasveld PE, Kitchener S, Edstein MD, Rieckmann KH, 2002. Comparison of tafenoquine (WR238605) and primaquine in the post exposure prophylaxis of vivax malaria in Australian Defence Force personnel. Trans R Soc Trop Med Hyg 96 : 683–684.
    [Google Scholar]
  4. Mihaly GW, Ward SA, Edwards G, Orme ML, Brekenridge AM, 1984. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol 17 : 441–446.
    [Google Scholar]
  5. Mihaly GW, Ward SA, Edwards G, Nicholl DD, Orme ML, Brekenridge AM, 1985. Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol 19 : 745–750.
    [Google Scholar]
  6. Ward SA, Mihaly GW, Edwards G, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA, Orme ML, Brekenridge AM, 1985. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. Br J Clin Pharmacol 19 : 751–755.
    [Google Scholar]
  7. Bhatia SC, Saraph YS, Revankar SN, Doshi KJ, Bharucha ED, Desai ND, Vaidya AB, Subrahmanyam D, Gupta KC, Satoskar RS, 1986. Pharmacokinetics of primaquine in patients with P. Vivax malaria. Eur J Clin Pharmacol 31 : 205–210.
    [Google Scholar]
  8. Bangchang KN, Songsaeng W, Thanavibul A, Choroenlarp P, Karbwang J, 1994. Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria. Trans R Soc Trop Med Hyg 88 : 220–222.
    [Google Scholar]
  9. Singhasivanon V, Sabcharoen A, Attanath P, Chongsuphajaisiddhi T, Diquet B, Turk P, 1991. Pharmacokinetics of primaquine in healthy volunteers. Southeast Asian J Trop Med Public Health 22 : 527–533.
    [Google Scholar]
  10. Gibaldi M, Perrier D, 1982. Pharmacokinetics. Second edition. New York: Dekker.

Data & Media loading...

  • Received : 13 Jul 2005
  • Accepted : 09 Feb 2006
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error